News
ACR and EULAR release first classification criteria for IgG4-related disease
- Author:
- Jeff Craven
In two validation cohorts, the criteria had specificities of 97.8%-99.2% and sensitivities of 82.0%-85.5%.
News

VEDOSS study describes predictors of progression to systemic sclerosis
- Author:
- Jeff Craven
ATLANTA – When Raynaud’s phenomenon is present, risk for progression is best predicted by the presence of puffy fingers, disease-specific...
News

Tofacitinib improves disease activity in patients with polyarticular-course JIA
- Author:
- Jeff Craven
ATLANTA – The phase 3 trial looked at flare rate out to 44 weeks after patients first met response criteria following 18 weeks of open-label...
News
Repeat LTBI testing best in patients taking biologics with new risk factors
- Author:
- Jeff Craven
ATLANTA – Just 1.2% of patients taking biologics with negative tuberculosis test results converted to positive results in annual tuberculosis...
News
Lp(a) molar concentration flags CVD, diabetes risk
- Author:
- Jeff Craven
Higher lipoprotein(a) molar concentration is linked to an increased risk of cardiovascular disease, compared with apolipoprotein(a) size.
News

Perioperative antirheumatic drug use does not impact postsurgery infection rate in RA patients
- Author:
- Jeff Craven
ATLANTA – A higher Charlson Comorbidity Index and longer surgery time, rather than preop antirheumatic medications, increased risk of infection....
News

Tanezumab posts higher safety event rate than NSAIDs over 1 year in hip, knee OA
- Author:
- Jeff Craven
ATLANTA – More safety events were seen with the higher 5-mg dose than with 2.5 mg.
News

OA management guidelines forgo treatment hierarchy or order but emphasize severity, patient risk factors
- Author:
- Jeff Craven
ATLANTA – “For any individual patient, a single option may be chosen at a particular time point, perhaps with or without other options, and may be...
News

Elagolix is effective second-tier treatment for endometriosis-associated dysmenorrhea
- Author:
- Jeff Craven
PHILADELPHIA – It has a very low adverse event profile and is well tolerated.
News

Fewer people are dying from systemic sclerosis at younger ages
- Author:
- Jeff Craven
ATLANTA – Mortality of people with systemic sclerosis in the United States aged 44 and younger now rivals the death rate for the general...
News

Early postmenopausal risk management leads to ‘optimum health’ for women
- Author:
- Jeff Craven
PHILADELPHIA – “There’s a major opportunity for us at the onset of menopause to identify risks and initiate preventive strategies.”
News
Most charity assistance programs do not cover prescriptions for uninsured patients
- Author:
- Jeff Craven
Cancer or cancer-related treatments were covered by 41% of programs, and 34% provided assistance for genetic or rare diseases.
News

PREVENT trial shows benefits of secukinumab for nonradiographic axSpA
- Author:
- Jeff Craven
ATLANTA – The trial of 555 patients “is the largest study done for a biologic agent in nonradiographic axial spondyloarthritis,” said Dr. Atul A....
News

Women undergoing hysterectomy, myomectomy have similar short-term outcomes
- Author:
- Jeff Craven
PHILADELPHIA – Patients had similar fibroid treatment benefits despite different baseline characteristics.
News

EHR treat-to-target prompts spur RA medication management decisions
- Author:
- Jeff Craven
ATLANTA – The alert system led to increased decisions to escalate or deescalate therapy.